Results 261 to 270 of about 732,665 (350)
Case Report: Emergency mitral valve plasty in an unstable dog with left atrial rupture secondary to myxomatous mitral valve disease. [PDF]
Wada T +6 more
europepmc +1 more source
This study tests NeuroD1 AAV‐based gene therapy in a non‐human primate Alzheimer's disease model. The therapy prevents neuronal damage, inhibits hippocampal atrophy, and reduces neuroinflammation. It also repairs vascular and blood‐brain barrier damage, restores cerebrospinal fluid biomarkers, enhances hippocampal glucose metabolism, and improves ...
Zhouquan Jiang +21 more
wiley +1 more source
A dural displacement sign in patients with type 1 cerebrospinal fluid leakage. [PDF]
Smilkov EA +6 more
europepmc +1 more source
Paraventricular CRF neurons in the hypothalamus project to glutamatergic neurons of the spinal trigeminal caudal nucleus, enhancing neuronal activation and CRFR2 signaling. This pathway increases CRF release and excitatory drive, promoting central sensitization and migraine‐related behaviors. Targeting the PVN–SP5C circuit provides a potential strategy
Jiang Bian +13 more
wiley +1 more source
Increased MRI-derived parenchymal cerebral spinal fluid mapping in untreated obstructive sleep apnea patients. [PDF]
Keil SA +8 more
europepmc +1 more source
Microbial synthesis of nanomaterials (NMs) is eco‐friendly, but the screening of microorganisms is limited by inefficient traditional methods (currently only involving∽400 microorganisms/90 NMs). We propose AI framework MicrobeDiscover, integrating a knowledge graph of microbe‐NM interactions.
Ludi Wang +12 more
wiley +1 more source
C-reactive Protein/Albumin Ratio in Septic Polytrauma: Predictive Marker or Concurrent Indicator? [PDF]
Panda CK, Karim HM.
europepmc +1 more source
Analysis of cerebrospinal fluid flow waveforms with gated phase-contrast MR velocity measurements.
Rafeeque Bhadelia +2 more
openalex +1 more source
This study shows TGM2 is upregulated in AP, impairing macrophage efferocytosis by inhibiting the STAT6–GAS6 axis. The lactoferrin‐modified, ROS‐responsive LF‐LNP@si‐TGM2 targets pancreatic macrophages, silences TGM2, restores the axis, and alleviates AP.
Xuxu Liu +8 more
wiley +1 more source

